Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March-April 2021
2019冠状病毒病（COVID-19）mRNA疫苗在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）β（B.1.351）变种在专业护理机构暴发期间的感染有效性：弗吉尼亚州，2021年3月至4月
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac526
Moline, Heidi L; Keaton, Amelia; Rice, Whitney; Varghese, Jasmine; Deng, Li; Waters, Ansley; Barringer, Anna; Winston, Devonne; Fields, Virgie; Slifka, Kara Jacobs; Verani, Jennifer R; Schrag, Stephanie J; Jernigan, John; Tate, Jacqueline E; Fleming-Dutra, Katherine E
